Novo Nordisk A/S (NVO) R&D Investor Event Call (Transcript)

Core Insights - The focus of the call is on research and development (R&D) and the pipeline of Novo Nordisk, particularly in relation to the EASD conference [2][3] - Martin will provide opening remarks before engaging with questions from the audience, emphasizing the importance of the pipeline and R&D events [3] Company and Industry Summary - The presentation is part of the 61st Edition of the EASD held in Vienna, indicating the company's active participation in significant industry events [1] - The company acknowledges the unpredictability of future developments, especially concerning its pipeline, highlighting the inherent risks in R&D [2]